Danish high-end stereo and TV maker Bang & Olufsen said it had received approaches regarding a potential takeover offer, sending its shares soaring.» Read More
EMC and VMware shareholders saw stock prices plunge after Dell bought out EMC and are now asking for changes to the deal, says Re/Code.
The deal with Pfizer and Allergan is the largest inversion transaction on record. The "Fast Money" traders discuss other potential inversion targets.
Sports platform provider Fantex pulls its IPO, so we look at what some of the next steps might be.
Pfizer is buying Allergan for about $160 billion. CNBC's Meg Tirrell reports on the reaction by lobbyists and analysts.
CVC Capital Partners and the Canada Pension Plan Investment Board have agreed to acquire Petco for about $4.6 billion.
Despite what your economics professor told you, megamergers are good for investors, says trader Jack Ablin. Here's why.
CNBC's Eamon Javers reports on the political ramifications of the proposed $160 billion Pfizer and Allegan merger.
CNBC's Meg Tirrell details the $160 billion merger between Allergan and Pfizer.
Pfizer CEO Ian Read and Allergan CEO Brent Saunders discuss their $160 billion merger and the resulting pharmaceutical powerhouse.
If Diebold closes are deal with Wincor Nixdorf, it would become the world's largest ATM maker.
Barbara Ryan, Clermont Partners, weighs in on terms of the deal which is expected to close in the second half of 2016.
CNBC's Meg Tirrell reports details of the merger which will create the world's largest pharma company to be headquartered in Dublin, Ireland.
CNBC's Meg Tirrell breaks down terms of the deal which would create the world's largest pharma company.
Pfizer's record deal with Allergan will allow the New York-based drug giant to relocate to Ireland to cut its U.S. tax burden.
A private-equity firm and Canada Pension Plan Investment Board are nearing a deal to acquire Petco, valuing it at around $4.7 billion.
Peabody Energy said it had agreed to sell its New Mexico and Colorado coal assets to Bowie Resource Partners for $358 million in cash.
Vamil Divan, Credit Suisse analyst, discusses benefits of the mega deal, including tax inversion and freeing up funds for research and development.
U.S. automated teller machine maker Diebold has launched a $1.8 billion cash and share offer for German rival Wincor Nixdorf.
Michael Jones, CIO and chairman at Riverfront investment Group, explains why mergers like the Pfizer-Allergan deal are a logical "next best thing" for management.
Pfizer secured formal board approval on Sunday for its acquisition of Botox maker Allergan, according to people familiar with the matter.